Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres








Gamme d'année
1.
Clinics ; Clinics;71(6): 351-360, tab, graf
Article de Anglais | LILACS | ID: lil-787429

RÉSUMÉ

OBJECTIVE: To evaluate the functional and histological effects of ganglioside G(M1) and erythropoietin after experimental spinal cord contusion injury. METHODS: Fifty male Wistar rats underwent experimental spinal cord lesioning using an NYU-Impactor device and were randomly divided into the following groups, which received treatment intraperitoneally. The G(M1) group received ganglioside G(M1) (30 mg/kg); the erythropoietin group received erythropoietin (1000 IU/kg); the combined group received both drugs; and the saline group received saline (0.9%) as a control. A fifth group was the laminectomy group, in which the animals were subjected to laminectomy alone, without spinal lesioning or treatment. The animals were evaluated according to the Basso, Beattie and Bresnahan (BBB) scale, motor evoked potential recordings and, after euthanasia, histological analysis of spinal cord tissue. RESULTS: The erythropoietin group had higher BBB scores than the G(M1) group. The combined group had the highest BBB scores, and the saline group had the lowest BBB scores. No significant difference in latency was observed between the three groups that underwent spinal cord lesioning and intervention. However, the combined group showed a significantly higher signal amplitude than the other treatment groups or the saline group (p<0.01). Histological tissue analysis showed no significant difference between the groups. Axonal index was significantly enhanced in the combined group than any other intervention (p<0.01). CONCLUSION: G(M1) and erythropoietin exert therapeutic effects on axonal regeneration and electrophysiological and motor functions in rats subjected to experimental spinal cord lesioning and administering these two substances in combination potentiates their effects.


Sujet(s)
Animaux , Mâle , Érythropoïétine/pharmacologie , Ganglioside GM1/pharmacologie , Neuroprotecteurs/pharmacologie , Récupération fonctionnelle/effets des médicaments et des substances chimiques , Traumatismes de la moelle épinière/traitement médicamenteux , Association de médicaments , Érythropoïétine/usage thérapeutique , Ganglioside GM1/usage thérapeutique , Injections péritoneales , Locomotion/effets des médicaments et des substances chimiques , Modèles animaux , Nécrose , Répartition aléatoire , Rat Wistar , Temps de réaction/effets des médicaments et des substances chimiques , Traumatismes de la moelle épinière/anatomopathologie , Traumatismes de la moelle épinière/physiopathologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE